EQUITY RESEARCH MEMO
Suraksha Diagnostic
Generated 5/25/2026
Executive Summary
Conviction (model self-assessment)65/100
Suraksha Diagnostic is a comprehensive diagnostic services provider based in Kolkata, India, operating since 1992. With CAP and NABL accredited laboratories, the company offers a wide range of services including pathology, radiology (MRI, CT, digital X-ray), and advanced genomic testing across Eastern and North-Eastern India. By integrating molecular platforms and specialty consultations under one roof, Suraksha delivers holistic health assessments and prenatal genetic screening. Its established presence in a region with growing healthcare demand positions it as a key player in the Indian diagnostic market.
Upcoming Catalysts (preview)
- Q3 2026Regional expansion into underserved districts70% success
- TBDStrategic partnership with major hospital chains50% success
- Q1 2027Launch of AI-assisted diagnostic reporting60% success
Locked sections
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)